Latest news with #DrugTestingLaboratory
Hans India
26-06-2025
- Health
- Hans India
Karnataka govt flags 14 substandard drugs; tells chemists, docs, public to avoid them
Bengaluru: The Karnataka government's Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as 'substandard' on Wednesday. The state's Food Safety and Drug Administration department has directed chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell, or use these drugs and cosmetics, an official statement said. 'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' the statement added. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health.
The Print
25-06-2025
- Health
- The Print
Karnataka govt flags 14 substandard drugs; tells chemists, docs, public to avoid them
'In case they hold any stock, they are requested to inform the concerned area Drugs Inspector or Assistant Drugs Controller. The public is also advised not to use these drugs or cosmetics,' the statement added. The state's Food Safety and Drug Administration department has directed chemists, wholesalers, doctors, hospitals, and nursing homes not to stock, sell, or use these drugs and cosmetics, an official statement said. Bengaluru, Jun 25 (PTI) The Karnataka government's Drug Testing Laboratory declared 14 drugs manufactured by 14 different companies as 'substandard' on Wednesday. The substandard drugs include compound sodium lactate injection IP (Ringer-Lactate solution for injection) manufactured by Ultra Laboratories (batch no: KI124110) and Tam Bran Pharmaceuticals; Pomol-650 (Paracetamol tablets I P 650 mg) by Aban Pharmaceuticals (batch no: 13-4536) and MITO Q7 Syrup by Bion Therapeutics India (batch no: CHS-40170) among others. The department has urged strict compliance with these directions to safeguard public health. PTI GMS GMS SSK This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Express Tribune
07-04-2025
- Health
- Express Tribune
Dues dispute hits Holy Family Hospital
A dispute has erupted between the contractors supplying medicines and related materials and the administration of the city's largest Holy Family Hospital over the non-payment of millions of rupees. Contractors have rejected the hospital administration's acknowledgment of dues amounting to Rs230 million, insisting that the outstanding amount is Rs400 million. The hospital administration has maintained that payments will be made by June 30. According to the contractors, they have not received payments for goods supplied, and they are also being asked for donations. They claim they have a right to the payment for the supplied goods, which has yet to be paid. On the other hand, Dr Ijaz Butt, the Medical Superintendent of Holy Family Hospital, stated that with three months remaining until the end of the current financial year, the hospital will clear Rs230 million in dues based on the Drug Testing Laboratory (DTL) clearance of the supplied medicines. The outstanding dues will be processed by the end of the financial year. Dr Butt added that if payments are not made by June 30, the remaining dues will be considered as liabilities. He further clarified that donations are voluntary, and no one is being forced to donate.
